Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

OBJECTIVE: To assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its utility to monitor treatment response in relapsing-remitting multiple sclerosis. METHODS: We measured NfL in blood samples from 589 patient...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neurology
Auteurs principaux: Kuhle, Jens, Kropshofer, Harald, Haering, Dieter A., Kundu, Uma, Meinert, Rolf, Barro, Christian, Dahlke, Frank, Tomic, Davorka, Leppert, David, Kappos, Ludwig
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442011/
https://ncbi.nlm.nih.gov/pubmed/30737333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007032
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires